Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial
Safety Data Review Across published studies, CJC-1295 has demonstrated a favorable safety profile: Common Adverse Events Injection site reactions (redness, swelling, pain): the most frequently reported side effect Headache: mild and transient Diarrhea: reported in some subjects, particularly at higher doses Flushing: transient warmth or redness Dizziness: occasional and brief Serious Adverse Events One serious adverse event in the early clinical development program, a death that occurred in a subject during a study, drew attention
Understanding these risk factors is essential for both patients and healthcare professionals to optimise diabetes management safely
Thorne Berberine Dr
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes Polycystic Ovary Syndrome Obesity Classification Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility The Role of Polycystic Ovary Syndrome in Reproductive and Metabolic Health: Overview and Approaches for Treatment Why are women with polycystic ovary syndrome obese
